{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:17:42Z","timestamp":1791893862573,"version":"4.3.4"},"reference-count":76,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RG- 2016-05056"],"award-info":[{"award-number":["RG- 2016-05056"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.dmd.2025.100085","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T19:02:58Z","timestamp":1745866978000},"page":"100085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The impact of progressive chronic kidney disease on hepatic drug metabolism"],"prefix":"10.1016","volume":"53","author":[{"given":"Emily D.","family":"Hartjes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1550-9059","authenticated-orcid":false,"given":"Yong Jin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Velenosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kait F.","family":"Al","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Macklaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Kucey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy P.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5803-3380","authenticated-orcid":false,"given":"Gregory B.","family":"Gloor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8324-1472","authenticated-orcid":false,"given":"Bradley L.","family":"Urquhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmd.2025.100085_bib1","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1124\/jpet.105.085050","article-title":"Hypersensitivity of HIV-1-infected cells to reactive sulfonamide metabolites correlated to expression of the HIV-1 viral protein tat","volume":"314","author":"Arp","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.dmd.2025.100085_bib2","doi-asserted-by":"crossref","first-page":"e00114","DOI":"10.1128\/genomeA.00114-16","article-title":"Complete genome sequence of Turicibacter sp. strain H121, isolated from the feces of a contaminated germ-free mouse","volume":"4","author":"Auchtung","year":"2016","journal-title":"Genome Announc"},{"key":"10.1016\/j.dmd.2025.100085_bib3","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00228-014-1709-7","article-title":"Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins","volume":"70","author":"Barnes","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.dmd.2025.100085_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134311","article-title":"Gut-microbiota-metabolite axis in early renal function decline","volume":"10","author":"Barrios","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.dmd.2025.100085_bib5","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1099\/00207713-52-4-1263","article-title":"Turicibacter sanguinis gen. nov., sp. nov., a novel anaerobic, Gram-positive bacterium","volume":"52","author":"Bosshard","year":"2002","journal-title":"Int J Syst Evol Microbiol"},{"key":"10.1016\/j.dmd.2025.100085_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.chemosphere.2015.08.009","article-title":"Production of a bioflocculant from methanol wastewater and its application in arsenite removal","volume":"141","author":"Cao","year":"2015","journal-title":"Chemosphere"},{"issue":"Suppl 1","key":"10.1016\/j.dmd.2025.100085_bib7","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1073\/pnas.1000080107","article-title":"Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample","volume":"108","author":"Caporaso","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.dmd.2025.100085_bib8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/ndt\/gfq397","article-title":"Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease","volume":"26","author":"Carrero","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.dmd.2025.100085_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrg3182","article-title":"The human microbiome: at the interface of health and disease","volume":"13","author":"Cho","year":"2012","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.dmd.2025.100085_bib10","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1128\/JB.01328-10","article-title":"Draft genome sequence of Turicibacter sanguinis PC909, isolated from human feces","volume":"193","author":"Cu\u00edv","year":"2011","journal-title":"J Bacteriol"},{"key":"10.1016\/j.dmd.2025.100085_bib11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0009-9236(03)00015-8","article-title":"Cytochrome P4502C9 activity in end-stage renal disease","volume":"73","author":"Dreisbach","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100085_bib12","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1093\/bioinformatics\/btq461","article-title":"Search and clustering orders of magnitude faster than BLAST","volume":"26","author":"Edgar","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.dmd.2025.100085_bib13","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/00365520701204238","article-title":"Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens","volume":"42","author":"Falk","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.dmd.2025.100085_bib14","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1126\/science.aad3503","article-title":"Population-level analysis of gut microbiome variation","volume":"352","author":"Falony","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.dmd.2025.100085_bib15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/cem.2736","article-title":"Comparison of the variable importance in projection (VIP) and of the selectivity ratio (SR) methods for variable selection and interpretation","volume":"29","author":"Farr\u00e9s","year":"2015","journal-title":"J Chemom"},{"key":"10.1016\/j.dmd.2025.100085_bib16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/bph.12932","article-title":"Effect of erythropoietin on hepatic cytochrome P450 expression and function in an adenine-fed rat model of chronic kidney disease","volume":"172","author":"Feere","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.dmd.2025.100085_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.36","article-title":"The microbiota and chronic kidney diseases: a double-edged sword","volume":"5","author":"Felizardo","year":"2016","journal-title":"Clin Transl Immunology"},{"key":"10.1016\/j.dmd.2025.100085_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2049-2618-2-15","article-title":"Unifying the analysis of high-throughput sequencing datasets: characterizing RNA-seq, 16S rRNA gene sequencing and selective growth experiments by compositional data analysis","volume":"2","author":"Fernandes","year":"2014","journal-title":"Microbiome"},{"key":"10.1016\/j.dmd.2025.100085_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12915-014-0069-1","article-title":"The earth microbiome project: successes and aspirations","volume":"12","author":"Gilbert","year":"2014","journal-title":"BMC Biol"},{"key":"10.1016\/j.dmd.2025.100085_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015406","article-title":"Microbiome profiling by Illumina sequencing of combinatorial sequence-tagged PCR products","volume":"5","author":"Gloor","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.dmd.2025.100085_bib21","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1080\/10618600.2015.1131161","article-title":"Displaying variation in large datasets: plotting a visual summary of effect sizes","volume":"25","author":"Gloor","year":"2016","journal-title":"J Comput Graph Stat"},{"key":"10.1016\/j.dmd.2025.100085_bib22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1139\/cjm-2015-0821","article-title":"Compositional analysis: a valid approach to analyze microbiome high-throughput sequencing data","volume":"62","author":"Gloor","year":"2016","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.dmd.2025.100085_bib23","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.annepidem.2016.03.003","article-title":"It\u2019s all relative: analyzing microbiome data as compositions","volume":"26","author":"Gloor","year":"2016","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.dmd.2025.100085_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/toxins9020052","article-title":"p-Cresyl sulfate","volume":"9","author":"Gryp","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.dmd.2025.100085_bib25","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/sj.bjp.0704951","article-title":"Down-regulation of hepatic cytochrome p450 in chronic renal failure: role of uremic mediators","volume":"137","author":"Gu\u00e9vin","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.dmd.2025.100085_bib26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/toxins6020665","article-title":"Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients","volume":"6","author":"Ito","year":"2014","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.dmd.2025.100085_bib27","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1016\/S2214-109X(24)00050-0","article-title":"The major global burden of chronic kidney disease","volume":"12","author":"Jadoul","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.dmd.2025.100085_bib28","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1124\/jpet.102.034785","article-title":"Prevention of latently expressed CYP2C11, CYP3A2, and growth hormone defects in neonatally monosodium glutamate-treated male rats by the N-methyl-D-aspartate receptor antagonist dizocilpine maleate","volume":"302","author":"Kaufhold","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.dmd.2025.100085_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.475","article-title":"The effect of chronic kidney disease on CYP2B expression and activity in male Wistar rats","volume":"7","author":"Kucey","year":"2019","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.dmd.2025.100085_bib30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1021\/ac202450g","article-title":"CAMERA: an integrated strategy for compound spectra extraction and annotation of liquid chromatography\/mass spectrometry data sets","volume":"84","author":"Kuhl","year":"2012","journal-title":"Anal Chem"},{"key":"10.1016\/j.dmd.2025.100085_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.ackd.2015.10.002","article-title":"The effects of CKD on cytochrome P450-mediated drug metabolism","volume":"23","author":"Ladda","year":"2016","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.dmd.2025.100085_bib32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/toxins8120358","article-title":"Indoxyl sulfate-review of toxicity and therapeutic strategies","volume":"8","author":"Leong","year":"2016","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.dmd.2025.100085_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1574-6968.2007.00962.x","article-title":"Selection of bacteria originating from a human intestinal microbiota in the gut of previously germ-free rats","volume":"277","author":"Licht","year":"2007","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.dmd.2025.100085_bib75","doi-asserted-by":"crossref","first-page":"609700","DOI":"10.3389\/fimmu.2021.609700","article-title":"Alteration of the gut microbiome in chronic kidney disease patients and its association with serum free immunoglobulin light chains","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.dmd.2025.100085_bib34","article-title":"Changes in gut microbial community upon chronic kidney disease","volume":"18","author":"Liu","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.dmd.2025.100085_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13073-016-0307-y","article-title":"The healthy human microbiome","volume":"8","author":"Lloyd-Price","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.dmd.2025.100085_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2049-2618-1-12","article-title":"Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis","volume":"1","author":"Macklaim","year":"2013","journal-title":"Microbiome"},{"key":"10.1016\/j.dmd.2025.100085_bib37","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/gut.32.7.754","article-title":"Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure","volume":"32","author":"Magnusson","year":"1991","journal-title":"Gut"},{"key":"10.1016\/j.dmd.2025.100085_bib38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1023\/A:1023866030544","article-title":"Dealing with zeros and missing values in compositional data sets using nonparametric imputation","volume":"35","author":"Mart\u00edn-Fern\u00e1ndez","year":"2003","journal-title":"Math Geol"},{"key":"10.1016\/j.dmd.2025.100085_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2105-13-31","article-title":"PANDAseq: paired-end assembler for Illumina sequences","volume":"13","author":"Masella","year":"2012","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.dmd.2025.100085_bib40","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ki.2011.322","article-title":"Drug dosing consideration in patients with acute and chronic kidney disease\u2014a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Matzke","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.dmd.2025.100085_bib41","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMra071313","article-title":"Uremia","volume":"357","author":"Meyer","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dmd.2025.100085_bib42","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/sj.bjp.0706138","article-title":"Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450","volume":"144","author":"Michaud","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.dmd.2025.100085_bib43","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1681\/ASN.2006010035","article-title":"Role of parathyroid hormone in the downregulation of liver cytochrome P450 in chronic renal failure","volume":"17","author":"Michaud","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.dmd.2025.100085_bib44","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1254\/jphs.08042FP","article-title":"Effect of hemodialysis on hepatic cytochrome P450 functional expression","volume":"108","author":"Michaud","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.dmd.2025.100085_bib45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1475-2840-13-46","article-title":"N-Acetylcysteine prevents congenital heart defects induced by pregestational diabetes","volume":"13","author":"Moazzen","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.dmd.2025.100085_bib46","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1681\/ASN.2009010082","article-title":"ESRD impairs nonrenal clearance of fexofenadine but not midazolam","volume":"20","author":"Nolin","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.dmd.2025.100085_bib47","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/clpt.2008.59","article-title":"Emerging evidence of the impact of kidney disease on drug metabolism and transport","volume":"83","author":"Nolin","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100085_bib48","doi-asserted-by":"crossref","first-page":"D590","DOI":"10.1093\/nar\/gks1219","article-title":"The SILVA ribosomal RNA gene database project: improved data processing and web-based tools","volume":"41","author":"Quast","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.dmd.2025.100085_bib76","doi-asserted-by":"crossref","first-page":"2001936","DOI":"10.1002\/advs.202001936","article-title":"Alterations of the human gut microbiome in chronic kidney disease","volume":"7","author":"Ren","year":"2020","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.dmd.2025.100085_bib49","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1099\/ijs.0.64192-0","article-title":"Reclassification of Bacteroides distasonis, Bacteroides goldsteinii and Bacteroides merdae as Parabacteroides distasonis gen. nov., comb. nov., Parabacteroides goldsteinii comb. nov. and Parabacteroides merdae comb. nov","volume":"56","author":"Sakamoto","year":"2006","journal-title":"Int J Syst Evol Microbiol"},{"key":"10.1016\/j.dmd.2025.100085_bib50","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1128\/AEM.01541-09","article-title":"Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities","volume":"75","author":"Schloss","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.dmd.2025.100085_bib51","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/bi901786x","article-title":"The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor","volume":"49","author":"Schroeder","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.dmd.2025.100085_bib52","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/00498250400021804","article-title":"AhR and PPARalpha: antagonistic effects on CYP2B and CYP3A, and additive inhibitory effects on CYP2C11","volume":"35","author":"Shaban","year":"2005","journal-title":"Xenobiotica"},{"key":"10.1016\/j.dmd.2025.100085_bib53","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1124\/dmd.110.032367","article-title":"CYP3A4 catalytic activity is induced in confluent Huh7 hepatoma cells","volume":"38","author":"Sivertsson","year":"2010","journal-title":"Drug Metabol Dispos"},{"key":"10.1016\/j.dmd.2025.100085_bib54","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1021\/ac051437y","article-title":"XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification","volume":"78","author":"Smith","year":"2006","journal-title":"Anal Chem"},{"key":"10.1016\/j.dmd.2025.100085_bib55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","article-title":"Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI)","volume":"3","author":"Sumner","year":"2007","journal-title":"Metabolomics"},{"key":"10.1016\/j.dmd.2025.100085_bib56","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1124\/dmd.104.000521","article-title":"Effects of uremic toxins on hepatic uptake and metabolism of erythromycin","volume":"32","author":"Sun","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100085_bib57","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1053\/j.ajkd.2014.09.015","article-title":"Effect of CKD and dialysis modality on exposure to drugs cleared by nonrenal mechanisms","volume":"65","author":"Thomson","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.dmd.2025.100085_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1039\/C4MB00414K","article-title":"PLS\/OPLS models in metabolomics: the impact of permutation of dataset rows on the K-fold cross-validation quality parameters","volume":"11","author":"Triba","year":"2015","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.dmd.2025.100085_bib59","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/jcph.2104","article-title":"The impact of suboptimal 25-hydroxyvitamin D levels and cholecalciferol replacement on the pharmacokinetics of oral midazolam in control subjects and patients with chronic kidney disease","volume":"62","author":"Tuey","year":"2022","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.dmd.2025.100085_bib60","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: classification, concentration, and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.dmd.2025.100085_bib61","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.1096\/fj.14-258780","article-title":"Decreased nuclear receptor activity and epigenetic modulation associates with down-regulation of hepatic drug-metabolizing enzymes in chronic kidney disease","volume":"28","author":"Velenosi","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.dmd.2025.100085_bib62","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1124\/dmd.112.045245","article-title":"Down-regulation of hepatic CYP3A and CYP2C mediated metabolism in rats with moderate chronic kidney disease","volume":"40","author":"Velenosi","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100085_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/srep22526","article-title":"Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120","volume":"6","author":"Velenosi","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.dmd.2025.100085_bib64","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/mnfr.201200714","article-title":"Uremia and chronic kidney disease: the role of the gut microflora and therapies with pro- and prebiotics","volume":"57","author":"Vitetta","year":"2013","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.dmd.2025.100085_bib65","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.yrtph.2013.10.006","article-title":"Effect of uremic serum and uremic toxins on drug metabolism in human microsomes","volume":"68","author":"Volpe","year":"2014","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.dmd.2025.100085_bib66","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1021\/pr200093w","article-title":"Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1)","volume":"10","author":"Wikoff","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1016\/j.dmd.2025.100085_bib67","doi-asserted-by":"crossref","first-page":"D801","DOI":"10.1093\/nar\/gks1065","article-title":"HMDB 3.0-the human metabolome database in 2013","volume":"41","author":"Wishart","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.dmd.2025.100085_bib68","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000360010","article-title":"Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD","volume":"39","author":"Wong","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.dmd.2025.100085_bib69","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0006-2952(97)00264-5","article-title":"Developmental changes in the constitutive and inducible expression of cytochrome P450 3A2","volume":"54","author":"Wright","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.dmd.2025.100085_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0050156","article-title":"Evolution of symbiotic bacteria in the distal human intestine","volume":"5","author":"Xu","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.dmd.2025.100085_bib71","doi-asserted-by":"crossref","first-page":"D643","DOI":"10.1093\/nar\/gkt1209","article-title":"The SILVA and \u201call-species Living Tree Project (LTP)\u201d taxonomic frameworks","volume":"42","author":"Yilmaz","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.dmd.2025.100085_bib72","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100085_bib73","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13073-016-0296-x","article-title":"Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions","volume":"8","author":"Zhang","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.dmd.2025.100085_bib74","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1021\/pr3007792","article-title":"Intrarenal metabolomic investigation of chronic kidney disease and its TGF-\u03b21 mechanism in induced-adenine rats using UPLC Q-TOF\/HSMS\/MS(E)","volume":"12","author":"Zhao","year":"2013","journal-title":"J Proteome Res"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625090944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625090944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:58:45Z","timestamp":1777474725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625090944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0090955625090944"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100085","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of progressive chronic kidney disease on hepatic drug metabolism","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100085"}}